HaploX Biotechnology
Shenzhen
About HaploX Biotechnology
HaploX is a biotechnology company that aims to improve cancer patient management by integrating liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies. Its technologies include tools for extracting and amplifying ultra-low concentrations of DNA from liquid samples, performing tagged sequencing, and managing and analyzing the resulting data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $72.2M
- Funding stage: Late Stage Venture
- Last round: Series D (Jul 2022)
- Website: haplox.com
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/haplox-biotechnology-68468 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.